Difficulties in the interpretation of patch test reactions to ophthalmic beta-blockers.
Carrière
M
M
Department of Dermatology, CHU-Purpan, Toulouse, France.
Giordano-Labadie
F
F
Schwarze
H P
HP
Loche
F
F
Bazex
J
J
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D002354:Carteolol / Q000009:adverse effects*; D003233:Conjunctivitis, Allergic / Q000175:diagnosis / Q000209:etiology*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D003937:Diagnosis, Differential; D005188:False Negative Reactions; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D009883:Ophthalmic Solutions; D010328:Patch Tests / Q000592:standards*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D002354:Carteolol